The objective of the U.K. Prospective Diabetes Study (UKPDS), initiated in
1977, was set up to determine whether improved blood glucose control in peo
ple with type 2 diabetes will prevent the complications of diabetes. The UK
PDS was also designed to determine whether there are differences between co
nventional policy (diet therapy) and three different regimens of intensive
treatment policy, based on sulfonylurea, metformin, or insulin. Interim eff
icacy analyses revealed that the intensive policies with sulfonylurea, insu
lin, and metformin were equally effective in reducing fasting plasma glucos
e concentrations. However, glucose and HbA(1c) measurements steadily increa
sed with time, reflecting ongoing deterioration of beta-cell function. Card
iovascular disease was the major cause of complications, and the risk facto
rs included raised LDL cholesterol concentrations, low HDL cholesterol conc
entrations, elevated blood pressure, elevated HbA(1c), concentrations, and
smoking. A final study report was issued in September 1998, when the median
duration of therapy was 11 years.